New pretext for payment blockage exasperates Greek pharma
This article was originally published in Scrip
The Greek pharmaceutical industry association SFEE has reacted with exasperation to the latest reason for the ongoing failure of the Greek state to settle its debts. It reports that although funds are available to repay the money owed to pharmaceutical companies by IKA, the largest social security organization (from the end of 2011 incorporated into the state health insurer EOPYY), the settlement process has stalled with outstanding debts still around €260m.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.